While companies developing solutions that address the current pandemic may be receiving an influx of financial support, recovery for companies in other segments of the industry is slow.
Although transactions were down, they exceeded more than $450 million last month.
Eighty medtech transactions in Europe came in at a value of approximately $627.5 million.
Peter Micca of Deloitte discusses the changes that are happening within the healthcare ecosystem as a whole.
Overall activity in deals jumped 11% in North America.
Ernst & Young’s annual Pulse of the Industry report reveals decreasing global revenue and financing in the medtech industry.